-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Revolution Medicines, Raises Price Target to $280

Benzinga·08/27/2026 12:15:43
Listen to the news
HC Wainwright & Co. analyst Robert Burns maintains Revolution Medicines (NASDAQ:RVMD) with a Buy and raises the price target from $195 to $280.